ITMCTR2000004134尚未招募1 期
Pre clinical evaluation of Jieyu II granule in the treatment of depression
Shanghai Municipal Hospital Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- Male
入选标准
- •1. Both male and female, aged from 18 to 70 years (including 18 and 70 years old).
- •2. According to the diagnosis of mild to moderate depression, the score of Hamilton Depression Scale (17 item version) was 7 to 17.
- •3. Sign written informed consent.
排除标准
- •1. The score of Hamilton Depression Scale (17 item version) was less than 7 or > 18;
- •2. Excluding organic mental disorders, or depression caused by psychoactive substances and non addictive substances;
- •3. Women who are pregnant, breastfeeding or may become pregnant during the study and are unable to take effective contraceptive measures;
- •4. Obvious symptoms of heart, liver, kidney or other systems;
- •5. Laboratory examination and ECG examination have obvious clinical significance abnormalities, which can affect the drug evaluation or the safety of the subjects;
- •6. AST and ALT were 2.0 times higher than the upper limit of normal value;
- •7. Participated in other clinical drug research in the last month.
研究者
相似试验
招募中
1 期
Dermal Safety Study of JTE-052atopic dermatitisJPRN-jRCT2031230570Koretomo Ryosuke22
招募中
2 期
Dose finding study of JTE-051Interstitial Cystitis/Bladder Pain SyndromeJPRN-jRCT2031210042Koretomo Ryosuke150
进行中(未招募)
1 期
Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, after first line chemotherapyon Small Cell Lung Cancer Stage IIIB and IV after first Line ChemotherapyMedDRA version: 5.0Level: LLTClassification code 10029514EUCTR2004-001253-29-ESPharmaMar SA34
进行中(未招募)
1 期
study with AZD1775 combined with carboplatin in patients with ovarian cancer. An extra group with additional safety and anti-tumor activity in patients with Ovarian Cancer, lung cancer, cervical and endometrial cancer.EUCTR2010-019106-16-NLetherlands Cancer Institute (NKI)224
招募中
早期 1 期
JY231 Injection in the Treatment of Relapsed or Refractory B-cell LymphomaRelapsed or Refractory B-cell LymphomaNCT06045585Guangdong Second Provincial General Hospital20
